An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2024-658/coif). The authors have no conflicts of interest to declare.
Sterling RK, Patel K, Duarte-Rojo A, Asrani SK, Alsawas M, Dranoff JA, Fiel MI, Murad MH, Leung DH, Levine D, Taddei TH, Taouli B, Rockey DC.Sterling RK, et al.Hepatology. 2025 Jan 1;81(1):321-357. doi: 10.1097/HEP.0000000000000845. Epub 2024 Mar 15.Hepatology. 2025.PMID: 38489523No abstract available.
References
Cheemerla S, Balakrishnan M. Global Epidemiology of Chronic Liver Disease. Clin Liver Dis (Hoboken) 2021;17:365-70. 10.1002/cld.1061
-
DOI
-
PMC
-
PubMed
Yin X, Guo X, Liu Z, et al. Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2023;24:2844. 10.3390/ijms24032844
-
DOI
-
PMC
-
PubMed
Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020;73:202-9. 10.1016/j.jhep.2020.03.039
-
DOI
-
PubMed
Froehlich F, Lamy O, Fried M, et al. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci 1993;38:1480-4. 10.1007/BF01308607
-
DOI
-
PubMed
Sterling RK, Patel K, Duarte-Rojo A, et al. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology 2025;81:321-57. 10.1097/HEP.0000000000000845
-
DOI
-
PubMed